Society for Translational Oncology (STO) promotes high-quality, equitable patient care and fosters the discovery and clinical translation of important new therapies that enhance the practice of global oncology as well as supports the prevention and treatment of infectious diseases that impact cancer patients and others with weakened immune systems. STO is committed to diversity, inclusivity, and equity throughout our programs.